imiquimod has been researched along with clobetasol in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Baroni, A; Rossiello, L; Ruocco, E; Ruocco, V | 1 |
| Emons, G; Faber, M; Günthert, AR; Hellriegel, S; Knappe, G | 1 |
| Levine, VJ; Machler, BC; Mark, NM; Patel, U | 1 |
| Chaney, KC; Domingues, E; Scharf, MJ; Wiss, K | 1 |
| Innamaa, A; Palmer, J; Sanderson, P; Tidy, J | 1 |
| Dou, W; Hu, J; Sun, J; Zhao, Y | 1 |
| Fukuda, T; Okazaki, A; Shiohara, T; Yamazaki, Y | 1 |
| Borgia, F; Cannavò, SP; Giuffrida, R | 1 |
| Chitkara, D; Dalela, M; Mittal, A; Mohanty, S; Pukale, SS; Sharma, S; Singh, AK | 1 |
2 review(s) available for imiquimod and clobetasol
| Article | Year |
|---|---|
Imiquimod 5% cream induced psoriasis: a case report, summary of the literature and mechanism.
Topics: Adjuvants, Immunologic; Aged; Aminoquinolines; Anti-Inflammatory Agents; Biopsy; Clobetasol; Humans; Imiquimod; Keratosis, Actinic; Male; Psoriasis; Treatment Outcome; Ultraviolet Therapy | 2011 |
Imiquimod therapy for extramammary Paget's disease of the vulva: a viable non-surgical alternative.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Anti-Inflammatory Agents; Antineoplastic Agents; Clobetasol; Female; Humans; Imiquimod; Middle Aged; Paget Disease, Extramammary; Vulvar Neoplasms | 2013 |
7 other study(ies) available for imiquimod and clobetasol
| Article | Year |
|---|---|
Imiquimod contact pemphigus: a comment.
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Clobetasol; Contraceptives, Oral; Female; Humans; Imiquimod; Papillomavirus Infections; Pemphigus; Treatment Outcome; Vulvar Diseases; Vulvar Neoplasms | 2004 |
Early onset vulvar Lichen Sclerosus in premenopausal women and oral contraceptives.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aminoquinolines; Androgen Antagonists; Androstenes; Case-Control Studies; Chlormadinone Acetate; Clobetasol; Contraceptives, Oral; Cyproterone Acetate; Female; Glucocorticoids; Humans; Imiquimod; Incidence; Nandrolone; Premenopause; Progesterone; Retrospective Studies; Risk Factors; Treatment Outcome; Vulvar Lichen Sclerosus | 2008 |
Imiquimod reactivation of lichen planus.
Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aminoquinolines; Anti-Inflammatory Agents; Cheilitis; Clobetasol; Follow-Up Studies; Humans; Imiquimod; Lichen Planus; Lip; Male; Treatment Outcome | 2012 |
A comparison of the effects of topical treatment of calcipotriol, camptothecin, clobetasol and tazarotene on an imiquimod-induced psoriasis-like mouse model.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Animals; Anti-Inflammatory Agents; Calcitriol; Camptothecin; Clobetasol; Dermatologic Agents; Disease Models, Animal; Humans; Imiquimod; Mice; Mice, Inbred BALB C; Nicotinic Acids; Psoriasis; Topoisomerase I Inhibitors | 2014 |
Pretreatment with topical glucocorticosteroids to enhance the antitumour efficacy of imiquimod: long-term follow-up in Bowen disease.
Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; CD3 Complex; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Clobetasol; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Forkhead Transcription Factors; Glucocorticoids; Humans; Imiquimod; Ointments; Skin Neoplasms; T-Lymphocytes, Regulatory; Treatment Outcome | 2017 |
Two cases of erosive pustular dermatosis of the scalp occurring after topical 3.75% imiquimod for actinic keratoses.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Clobetasol; Dermatologic Agents; Drug Eruptions; Humans; Imiquimod; Keratosis, Actinic; Male; Scalp; Scalp Dermatoses; Treatment Outcome | 2019 |
Multi-component clobetasol-loaded monolithic lipid-polymer hybrid nanoparticles ameliorate imiquimod-induced psoriasis-like skin inflammation in Swiss albino mice.
Topics: Animals; Clobetasol; Imiquimod; Inflammation; Lipids; Mice; Nanoparticles; Polymers; Psoriasis | 2020 |